Circumventing cellular control of PP2A by methylation promotes transformation in an Akt-dependent manner

Neoplasia (United States)

Volumn 14, Issue 7, 2012, Pages 585-599

  Jackson, Jennifer B ^a   Pallas, David C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE CARBOXYL METHYLTRANSFERASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN CARBOXYL METHYLTRANSFERASE; PROTEIN KINASE B; PROTEIN P70; PROTEIN P85; S6 KINASE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VIRUS LARGE T ANTIGEN; VIRUS MIDDLE T ANTIGEN; VIRUS SMALL T ANTIGEN;

ANCHORAGE INDEPENDENT GROWTH; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE REGULATION; CELL DEATH; CELL GROWTH; CELL SIZE; CELL SURVIVAL; CELL SUSPENSION; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOLYSIS; ENZYME ACTIVE SITE; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN METHYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84865662302     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.12768     Document Type: Article

References (73)

1. Janssens V and Goris J (2001). Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 353, 417-439.
2. Haesen D, Sents W, Ivanova E, Lambrecht C, and Janssens V (2012). Cellular inhibitors of protein phosphatase PP2A in cancer. Biomed Res 23, SI 197-SI 211.
3. Westermarck J and Hahn WC (2008). Multiple pathways regulated by the tumor suppressor PP2A in transformation. Trends Mol Med 14, 152-160.
4. Westphal RS, Coffee RL Jr, Marotta A, Pelech SL, and Wadzinski BE (1999). Identification of kinase-phosphatase signaling modules composed of p70 S6 kinase-protein phosphatase 2A (PP2A) and p21-activated kinase-PP2A. J Biol Chem 274, 687-692.
5. Tolstykh T, Lee J, Vafai S, and Stock JB (2000). Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits. EMBO J 19, 5682-5691.
6. Wu J, Tolstykh T, Lee J, Boyd K, Stock JB, and Broach JR (2000). Carboxyl methylation of the phosphoprotein phosphatase 2A catalytic subunit promotes its functional association with regulatory subunits in vivo. EMBO J 19, 5672-5681.
7. Wei H, Ashby DG, Moreno CS, Ogris E, Yeong FM, Corbett AH, and Pallas DC (2001). Carboxymethylation of the PP2A catalytic subunit in Saccharomyces cerevisiae is required for efficient interaction with the B-type subunits Cdc55p and Rts1p. J Biol Chem 276, 1570-1577.
8. Yu XX, Du X, Moreno CS, Green RE, Ogris E, Feng Q, Chou L, McQuoid MJ, and Pallas DC (2001). Methylation of the protein phosphatase 2A catalytic subunit is essential for association of Bα regulatory subunit but not SG2NA, striatin, or polyomavirus middle tumor antigen. Mol Biol Cell 12, 185-199.
9. De Baere I, Derua R, Janssens V, Van Hoof C, Waelkens E, Merlevede W, and Goris J (1999). Purification of porcine brain protein phosphatase 2A leucine carboxyl methyltransferase and cloning of the human homologue. Biochemistry 38, 16539-16547.
10. Lee J, Chen Y, Tolstykh T, and Stock J (1996). A specific protein carboxyl methylesterase that demethylates phosphoprotein phosphatase 2A in bovine brain. Proc Natl Acad Sci USA 93, 6043-6047.
11. Ogris E, Du X, Nelson KC, Mak EK, Yu XX, Lane WS, and Pallas DC (1999). A protein phosphatase methylesterase (PME-1) is one of several novel proteins stably associating with two inactive mutants of protein phosphatase 2A. J Biol Chem 274, 14382-14391.
12. Longin S, Zwaenepoel K, Louis JV, Dilworth S, Goris J, and Janssens V (2007). Selection of protein phosphatase 2A regulatory subunits is mediated by the C terminus of the catalytic subunit. J Biol Chem 282, 26971-26980.
13. Kuo YC, Huang KY, Yang CH, Yang YS, Lee WY, and Chiang CW (2008). Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55α regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt. J Biol Chem 283, 1882-1892.
14. Sablina AA, Hector M, Colpaert N, and Hahn WC (2010). Identification of PP2A complexes and pathways involved in cell transformation. Cancer Res 70, 10474-10484.
15. Rocher G, Letourneux C, Lenormand P, and Porteu F (2007). Inhibition of B56-containing protein phosphatase 2As by the early response gene IEX-1 leads to control of Akt activity. J Biol Chem 282, 5468-5477.
16. Petritsch C, Beug H, Balmain A, and Oft M (2000). TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G1 arrest. Genes Dev 14, 3093-3101.
17. Pallas DC, Shahrik LK, Martin BL, Jaspers S, Miller TB, Brautigan DL, and RobertsTM(1990). Polyoma small and middleTantigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell 60, 167-176.
18. Ogris E, Gibson DM, and Pallas DC (1997). Protein phosphatase 2A subunit assembly: the catalytic subunit carboxy terminus is important for binding cellular B subunit but not polyomavirus middle tumor antigen. Oncogene 15, 911-917.
19. Yang SI, Lickteig RL, Estes R, Rundell K, Walter G, and Mumby MC (1991). Control of protein phosphatase 2A by simian virus 40 small-t antigen. Mol Cell Biol 11, 1988-1995.
20. Scheidtmann KH, Mumby MC, Rundell K, and Walter G (1991). Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen. Mol Cell Biol 11, 1996-2003.
21. Sontag E, Fedorov S, Kamibayashi C, Robbins D, Cobb M, and Mumby M (1993). The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates theMAP kinase pathway and induces cell proliferation. Cell 75, 887-897.
22. Ulug ET, Cartwright AJ, and Courtneidge SA (1992). Characterization of the interaction of polyomavirus middle T antigen with type 2A protein phosphatase. J Virol 66, 1458-1467.
23. Chen W, Possemato R, Campbell KT, Plattner CA, Pallas DC, and Hahn WC (2004). Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell 5, 127-136.
24. Pallas DC, Weller W, Jaspers S, Miller TB, Lane WS, and Roberts TM (1992). The third subunit of protein phosphatase 2A (PP2A), a 55-kilodalton protein which is apparently substituted for byTantigens in complexeswith the 36-and 63-kilodalton PP2A subunits, bears little resemblance to T antigens. J Virol 66, 886-893.
25. Gillet R, Cavard C, Grimber G, Briand P, and Joulin V (2001). Hepatic expression of SV40 small-T antigen blocks the in vivo CD95-mediated apoptosis. Biochem Biophys Res Comm 284, 369-376.
26. Zhao JJ, Gjoerup OV, Subramanian RR, Cheng Y, Chen W, Roberts TM, and Hahn WC (2003). Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell 3, 483-495.
27. Yuan H, Veldman T, Rundell K, and Schlegel R (2002). Simian virus 40 small tumor antigen activates AKT and telomerase and induces anchorage-independent growth of human epithelial cells. J Virol 76, 10685-10691.
28. Sontag E, Sontag JM, and Garcia A (1997). Protein phosphatase 2A is a critical regulator of protein kinase C ζ signaling targeted by SV40 small t to promote cell growth and NF-κB activation. EMBO J 16, 5662-5671.
29. Moreno CS, Ramachandran S, Ashby DG, Laycock N, Plattner CA, Chen W, Hahn WC, and Pallas DC (2004). Signaling and transcriptional changes critical for transformation of human cells by simian virus 40 small tumor antigen or protein phosphatase 2A B56γ knockdown. Cancer Res 64, 6978-6988.
30. Nunbhakdi-Craig V, Schuechner S, Sontag JM, Montgomery L, Pallas DC, Juno C, Mudrak I, Ogris E, and Sontag E (2007). Expression of protein phosphatase 2A mutants and silencing of the regulatory Bα subunit induce a selective loss of acetylated and detyrosinated microtubules. J Neurochem 101, 959-971.
31. Lee JA and Pallas DC (2007). Leucine carboxyl methyltransferase-1 is necessary for normal progression through mitosis in mammalian cells. J Biol Chem 282, 30974-30984.
32. Kitamura T, Ogawa W, Sakaue H, Hino Y, Kuroda S, Takata M, Matsumoto M, Maeda T, Konishi H, Kikkawa U, et al. (1998). Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol Cell Biol 18, 3708-3717.
33. Pallas DC, Schley C, Mahoney M, Harlow E, Schaffhausen BS, and Roberts TM (1986). Polyomavirus small t antigen: overproduction in bacteria, purification, and utilization for monoclonal and polyclonal antibody production. J Virol 60, 1075-1084.
34. Gordon J, Hwang J, Carrier KJ, Jones CA, Kern QL, Moreno CS, Karas RH, and Pallas DC (2011). Protein phosphatase 2a (PP2A) binds within the oligomerization domain of striatin and regulates the phosphorylation and activation of the mammalian Ste-Like kinase Mst3. BMC Biochem 12, e54.
35. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, and Weinberg RA (1999). Creation of human tumour cells with defined genetic elements. Nature 400, 464-468.
36. Cifone M and Fidler IJ (1980). Correlation of patterns of anchorage-independent growth with in vivo behavior of cells for a murine fibroblast. Proc Natl Acad Sci USA 77, 1039-1043.
37. Stanevich V, Jiang L, Satyshur KA, Li Y, Jeffrey PD, Li Z, Menden P, Semmelhack MF, and Xing Y (2011). The structural basis for tight control of PP2A methylation and function by LCMT-1. Mol Cell 41, 331-342.
38. Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, Sabatini DM, DeCaprio JA, and Weinberg RA (2002). Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 22, 2111-2123.
39. Freedman VH and Shin S (1974). Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3, 355-359.
40. Vachon PH (2011). Integrin signaling, cell survival, and anoikis: distinctions, differences, and differentiation. J Signal Transduct 2011, 738137.
41. Song G, Ouyang G, and Bao S (2005). The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9, 59-71.
42. Jope RS and Johnson GV (2004). The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29, 95-102.
43. Peterson RT and Schreiber SL (1998). Translation control: connecting mitogens and the ribosome. Curr Biol 8, R248-R250.
44. Lantier L, Mounier R, Leclerc J, Pende M, Foretz M, and Viollet B (2010). Coordinated maintenance of muscle cell size control by AMP-activated protein kinase. FASEB J 24, 3555-3561.
45. Hay N and Sonenberg N (2004). Upstream and downstream of mTOR [review]. Genes Dev 18, 1926-1945.
46. Mamane Y, Petroulakis E, LeBacquer O, and Sonenberg N (2006). mTOR, translation initiation and cancer. Oncogene 25, 6416-6422.
47. Li SP, Brignole C, Marcellus R, Thirlwell S, Binda O, McQuoid MJ, Ashby D, Chan H, Zhang Z, Miron MJ, et al. (2009). The adenovirus E4orf4 protein induces G2/M arrest and cell death by blocking protein phosphatase 2A activity regulated by the B55 subunit. J Virol 83, 8340-8352.
48. Sontag JM and Sontag E (2006). Regulation of cell adhesion by PP2A and SV40 small tumor antigen: an important link to cell transformation. Cell Mol Life Sci 63, 2979-2991.
49. Nho RS and Peterson M (2011). Eukaryotic translation initiation factor 4E binding protein 1 (4EBP-1) function is suppressed by src and protein phosphatase 2A (PP2A) on extracellular matrix. J Biol Chem 286, 31953-31965.
50. Nho RS and Kahm J (2010). β1-Integrin-collagen interaction suppresses Fox-O3a by the coordination of Akt and PP2A. J Biol Chem 285, 14195-14209.
51. Kiely PA, Baillie GS, Lynch MJ, Houslay MD, and O'Conner R (2008). Tyrosine 302 in RACK1 is essential for insulin-like growth factor-I-mediated competitive binding of PP2A and B1 integrin and for tumor cell proliferation and migration. J Biol Chem 283, 22952-22961.
52. Xia H, Nho R, Kleidon J, Kahm J, and Henke CA (2008). Polymerized collagen inhibits fibroblast proliferation via a mechanism involving the formation of a B1 integrin-protein phosphatase 2A-tuberous sclerosis complex 2 complex that suppresses S6K1 activity. J Biol Chem 283, 20350-20360.
53. De Toni-Costes F, Despeaux M, Bertrand J, Bourogaa E, Ysebaert L, Payrastre B, and Racaud-Sultan C (2010). A new α5β1 integrin-dependent survival pathway through GSK3B activation in leukemic cells. PLoS One 5, e9807.
54. Gendron S, Couture J, and Aoudjit F (2003). Integrin α2β1 inhibits Fas-mediated apoptosis in T lymphocytes by protein phosphatase 2A-dependent activation of the MAPK/ERK pathway. J Biol Chem 278, 48633-48643.
55. Chen J,Martin BL, and BrautiganDL (1992).Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science 257, 1261-1264.
56. Ramel D, Lagarrigue F, Dupruis-Coronas S, Chicanne G, Leslie N, Gaits-Iacovoni F, Payrastre B, and Tronchere H (2009). PtdIns5P protects Akt from dephosphorylation through PP2A inhibition. Biochem Biophys Res Commun 387, 127-131.
57. Bielinski VA and Mumby MC (2007). Functional analysis of the PP2A subfamily of protein phosphatases in regulating drosophila S6 kinase. Exp Cell Res 313, 3117-3126.
58. Hombauer H, Weismann D, Mudrak I, Stanzel C, Fellner T, Lackner DH, and Ogris E (2007). Generation of active protein phosphatase 2A is coupled to holoenzyme assembly. PLoS Biol 5, e155.
59. Ortega-Gutierrez S, Leung D, Ficarro S, Peters EC, and Cravatt BF (2008). Targeted disruption of the pme-1 gene causes loss of demethylated PP2A and perinatal lethality in mice. PLoS One 3, e2486.
60. Puustinen P, Junttila MR, Vanhatupa S, Sablina AA, Hector ME, Teittinen K, Raheem O, Ketola K, Lin S, Kast J, et al. (2009). Pme-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma. Cancer Res 69, 2870-2877.
61. Kennedy IM and Leader DP (1981). Increased phosphorylation of ribosomal protein S6 in hamster fibroblasts transformed by polyoma virus and simian virus 40. Biochem J 198, 235-237.
62. Blenis J and Erikson RL (1984). Phosphorylation of the ribosomal protein S6 is elevated in cells transformed by a variety of tumor viruses. J Virol 50, 966-969.
63. Talmage DA, Blenis J, and Benjamin TL (1988). Polyomavirus middle T antigen induces ribosomal protein S6 phosphorylation through pp60c-src-dependent and -independent pathways. Mol Cell Biol 8, 2309-2315.
64. Meili R, Cron P, Hemmings BA, and Ballmer-Hofer K (1998). Protein kinase B/Akt is activated by polyomavirus middle-T antigen via a phophatidylinositol 3-kinase-dependent mechanism. Oncogene 16, 903-907.
65. Dahl J, Jurczak A, Cheng LA, Baker DC, and Benjamin TL (1998). Evidence of a role for phosphatidylinositol 3-kinase activation in the blocking of apoptosis by polyomavirus middle T antigen. J Virol 72, 3221-3226.
66. Andrabi S, Gjoerup OV, Kean JA, Roberts TM, and Schaffhausen B (2007). Protein phosphatase 2A regulates life and death decisions via Akt in a contextdependent manner. Proc Natl Acad Sci USA 104, 19011-19016.
67. Calvo E, Bolos V, and Grande E (2009). Multiple roles and therapeutic implications of Akt signaling and cancer. Onco Targets Ther 2, 135-150.
68. Jastrzebski K, Hannan KM, Tchhoubrieva EB, Hannan RD, and Pearson RB (2007). Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function. Growth Factors 25, 209-226.
69. Nozawa H, Watanabe T, and Nagawa H (2007). Phosphorylation of ribosomal p70 S6 kinase and rapamycin sensitivity in human colorectal cancer. Cancer Lett 251, 105-113.
70. Zhou Y, Pan Y, Zhang S, Shi X, Ning T, and Ke Y (2007). Increased phosphorylation of p70 S6 kinase is associated with HPV16 infection in cervical cancer and esophageal cancer. Br J Cancer 97, 218-222.
71. Castellvi J, Garcia A, Rojo F, Ruiz-Marcellan C, Gil A, Baselga J, and Ramon y Cajal S (2006). Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer. Cancer 107, 1801-1811.
72. Kwon HK, Bae GU, Yoon JW, Kim YK, Lee HY, Lee HW, and Han JW (2002). Constitutive activation of p70 S6K in cancer cells. Arch Pharm Res 25, 685-690.
73. Barlund M, Forozan F, Kononen J, Bubendorf L, Chen Y, Bittner ML, Torhorst J, Haas P, Bucher C, Guido S, et al. (2000). Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J NCI 92, 1252-1259.